0001185185-24-000264.txt : 20240315 0001185185-24-000264.hdr.sgml : 20240315 20240315212700 ACCESSION NUMBER: 0001185185-24-000264 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240313 FILED AS OF DATE: 20240315 DATE AS OF CHANGE: 20240315 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GRIMALDI CLAUDIA CENTRAL INDEX KEY: 0001745853 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32830 FILM NUMBER: 24756771 MAIL ADDRESS: STREET 1: PO BOX 60642 CITY: POTOMAC STATE: MD ZIP: 20859 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IGC Pharma, Inc. CENTRAL INDEX KEY: 0001326205 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 202760393 STATE OF INCORPORATION: MD FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 10224 FALLS ROAD CITY: POTOMAC STATE: MD ZIP: 20854 BUSINESS PHONE: 301-983-0998 MAIL ADDRESS: STREET 1: 10224 FALLS ROAD CITY: POTOMAC STATE: MD ZIP: 20854 FORMER COMPANY: FORMER CONFORMED NAME: India Globalization Capital, Inc. DATE OF NAME CHANGE: 20050505 4 1 ownership.xml X0508 4 2024-03-13 0 0001326205 IGC Pharma, Inc. IGC 0001745853 GRIMALDI CLAUDIA 10224 FALLS ROAD POTOMAC MD 20854 1 0 0 0 0 Common Stock 2024-03-13 4 M 0 83333 0.0 A 783821 D Common Stock 2024-03-13 4 M 0 58333 0.0 A 842154 D Common Stock 2024-03-13 4 M 0 100000 0.0 A 942154 D Common Stock 2024-03-13 4 M 0 95000 0.0 A 1037154 D Restricted Stock Units 2024-03-13 4 M 0 83333 0.0 D Common Stock 83333 0 D Restricted Stock Units 2024-03-13 4 M 0 58334 0.0 D Common Stock 58334 58332 D Restricted Stock Units 2024-03-13 4 M 0 100000 0.0 D Common Stock 100000 200000 D Restricted Stock Units 2024-03-13 4 M 0 95000 0.0 D 2033-03-31 Common Stock 95000 285000 D Options 2024-03-13 4 A 0 360000 0.0 A Common Stock 360000 360000 D Options 2024-03-13 4 A 0 550000 0.0 A 2034-03-31 Common Stock 550000 550000 D On July 19, 2021, the Reporting Person was granted RSUs subject to vesting equally over three years starting on March 2022. On May 25, 2022, the Reporting Person was granted RSUs subject to vesting equally over three years starting on March 2023. On June 20, 2023, the Reporting Person was granted RSUs subject to vesting equally over three years starting on March 2024. On June 20, 2023, the Reporting Person was granted RSUs subject to vesting according to specific milestones set by the Company's Board of Directors. The RSUs vest when milestones are achieved. Each restricted stock unit represents a right to receive one share of IGC common stock. On March 13, 2024, the Reporting Person was granted Options subject to vesting equally over three years starting on March 2025. The exercise price is $0.26. On March 13, 2024, the Reporting Person was granted Options subject to vesting according to specific milestones set by the Company's Board of Directors. The Options vest when milestones are achieved. The exercise price is $0.26. s/ Claudia Grimaldi 2024-03-15